Inhibitor Therapeutics, Inc. INTI
0.06 USD 0.00 (-3.27%)
Nov 3, 2026, 9:30 AM EST
0.0591 Day range 0.0591
0.04 52-week range 0.124
- YTD
- +31.33%
- 1 year
- +18.20%
- Market cap
- 10.33M
- EPS (ttm)
- -0.02
- YTD return
- +31.33%
- 1-year return
- +18.20%
- Volume
- 500
- Avg volume
- 7.59K
- Open
- 0.0591
- Previous close
- 0.0611
- Day's range
- 0.0591 – 0.0591
- 52-week range
- 0.04 – 0.124
2Y +0.0120 (+14.12%)
News
Inhibitor Therapeutics Highlights Key Developments and Reminds Stockholders of September 15 Annual Meeting 
Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome 
Complement Inhibitor Therapeutics Pipeline Developments Research Report 2024 
Complement Inhibitors Clinical Trial Pipeline Analysis: 40+ Key Companies Shaping the Future of Complement Inhibitor Therapeutics | DelveInsight 
Inhibitor Therapeutics, Inc. Provides Update on its Clinical Development Plan 
3 Intriguing Stocks to Watch as Earnings Approach 
Introducing Inhibitor Therapeutics, Inc. New Scientific Advisory Board
Your note
Sign in to keep a note on INTI — it syncs with the Stock Master app.